# Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness

> **NCT03824834** · PHASE2 · UNKNOWN · sponsor: **Dennis Jensen, Ph.D.** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Interstitial Lung Disease

## Interventions

- **DRUG:** Exercise training with morphine
- **OTHER:** Exercise training with placebo

## Key facts

- **NCT ID:** NCT03824834
- **Lead sponsor:** Dennis Jensen, Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03824834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03824834, "Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03824834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*